Sales Highlights (unaudited): Global•Q1 sales AUD$2.0 million up 34$1.6 million up 52% on pcp   Canada•Q1 sales AUD$0.0 million down 92$0.4 million up 44% on pcp MELBOURNE, Australia, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce continued sales growth (unaudited) of Travelan®, an over-the-counter imm ...